There is no substitute for safety when prescribing medication.

Get a current list of pharmacies in the network or find out which drugs are on the formulary:

Search Pharmacies buttonSearch Formulary button

 

 

Important: The formulary and search do not apply to Medicare Advantage Plan members. Please refer to the Community HealthFirst site for information on Medicare Plan coverage.

The 2018 formulary is still available here: Search the 2018 formulary

Changes Coming to 2019 Formulary

On January 1, 2019, all managed care plans and Apple Health fee-for-service programs will continue to phase in a Single Preferred Drug List (PDL).

This change is mandated by the Washington State Legislature.

The Health Care Authority is working with managed care plans that serve Apple Health clients to create the Apple Health PDL. On January 1, 2019, the PDL will be adding an additional 74 drug classes. Managed care plans will continue to use their own preferred drug lists for drugs not included in the Apple Health PDL.

We will continue to provide more information to ensure a smooth transition for providers and patients to the Single Preferred Drug List. Please contact customercare@chpw.org with any questions.

Prior Authorization

To request a prior authorization, step therapy, nonformulary, or quantity limit override, please call ESI at 1-844-605-8168, 24 hours a day, 7 days a week, and speak to a prior authorization service specialist. This specialist will review medical information and criteria with the provider or designee regarding the need for the requested drug. 

Pharmacy Reimbursement Issues

If you are having an issue with reimbursement, please submit an inquiry to ESI through their Pharmacist Resource Center

Pharmacy Emergency Fills

Emergency fills may be covered to prevent interruptions in therapy during an emergency. View our policy on emergency fills on our Policies and Procedures page.

Carved out drugs: Covered by Fee-for-Service

  • Axicabtagene ciloleucel (Yescarta)
  • Burosumab-twza (Crysvita)- effective 1/1/19
  • Cerliponase alfa (Brineura)
  • Edavarone (Radicava)
  • Eterplirsen (Exondys 51)
  • Nusinersen (Spinraza)
  • Pegvaliase-pgpz (Palynziq)- - effective 1/1/19
  • Tisagenlecleucel-t (Kymriah)
  • Voretigene neparvovec-rzyl (Luxterna)  
  • Dental Prescriptions
  • Hepatitis C medication
  • Hemophilia medication

The Washington State HCA will be responsible for ALL pre-authorizations and approvals for therapy based on HCA clinical guidelines. HCA Policy is available here

Medication Therapy Management

Coverage for Medication Therapy Management services is now available to Apple Health providers and members who meet certain eligibility requirements listed below.

MTM Eligibility Requirements

If you are a Medicare Advantage member, visit the Community HealthFirst website for information on Medicare HealthFirst Medication Therapy information.

Pharmacy and Therapeutics (P&T) Committee

Our P&T Committee meets to evaluate our formulary, prior authorization requirements, and safety measures to ensure quality. Read the most recent decisions:

  • November 14, 2018: No Clinical Decisions
  • July 13, 2018: No Clinical Decisions
  • March 2, 2018: No Clinical Decisions
  • November 17, 2017: No Clinical Decisions

Medication Safety

Be sure to read the latest Drug Recall Report for updates on medications that are recalled due to safety issues.